Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADAP |
---|---|---|
09:32 ET | 45762 | 1.06 |
09:34 ET | 508 | 1.08 |
09:36 ET | 508 | 1.08 |
09:38 ET | 13330 | 1.05 |
09:39 ET | 17000 | 1.05 |
09:41 ET | 12848 | 1.04 |
09:43 ET | 900 | 1.04 |
09:45 ET | 3487 | 1.0416 |
09:48 ET | 35800 | 1.05 |
09:50 ET | 4065 | 1.04 |
09:52 ET | 1480 | 1.04 |
09:54 ET | 6100 | 1.056 |
09:56 ET | 1400 | 1.06 |
09:57 ET | 4057 | 1.05 |
09:59 ET | 2405 | 1.045 |
10:01 ET | 53790 | 1.04 |
10:03 ET | 1200 | 1.0501 |
10:06 ET | 16042 | 1.0504 |
10:08 ET | 1578 | 1.06 |
10:10 ET | 1837 | 1.0575 |
10:12 ET | 5580 | 1.07 |
10:14 ET | 7300 | 1.06 |
10:15 ET | 3866 | 1.05 |
10:17 ET | 13924 | 1.08 |
10:19 ET | 200 | 1.08 |
10:21 ET | 7200 | 1.0703 |
10:24 ET | 6083 | 1.07 |
10:26 ET | 3600 | 1.06 |
10:28 ET | 2500 | 1.06 |
10:30 ET | 4476 | 1.05 |
10:32 ET | 3250 | 1.055 |
10:33 ET | 1000 | 1.05 |
10:35 ET | 6399 | 1.06 |
10:37 ET | 2481 | 1.06 |
10:39 ET | 100 | 1.05 |
10:44 ET | 12359 | 1.04 |
10:46 ET | 400 | 1.04 |
10:48 ET | 800 | 1.04 |
10:50 ET | 3087 | 1.0553 |
10:51 ET | 600 | 1.06 |
10:53 ET | 985 | 1.06 |
10:55 ET | 300 | 1.06 |
10:57 ET | 200 | 1.06 |
11:00 ET | 3100 | 1.0528 |
11:02 ET | 790 | 1.055 |
11:04 ET | 300 | 1.06 |
11:06 ET | 700 | 1.06 |
11:08 ET | 2200 | 1.06 |
11:09 ET | 3600 | 1.05 |
11:11 ET | 200 | 1.055 |
11:13 ET | 600 | 1.05 |
11:15 ET | 3800 | 1.055 |
11:18 ET | 4056 | 1.055 |
11:20 ET | 100 | 1.055 |
11:22 ET | 300 | 1.055 |
11:24 ET | 2300 | 1.055 |
11:26 ET | 1693 | 1.06 |
11:27 ET | 1900 | 1.05 |
11:29 ET | 400 | 1.06 |
11:31 ET | 2169 | 1.045 |
11:36 ET | 100 | 1.05 |
11:38 ET | 900 | 1.05 |
11:40 ET | 5600 | 1.0401 |
11:42 ET | 300 | 1.05 |
11:45 ET | 1462 | 1.04 |
11:49 ET | 100 | 1.045 |
11:54 ET | 800 | 1.05 |
12:02 ET | 300 | 1.05 |
12:03 ET | 700 | 1.04 |
12:05 ET | 11990 | 1.0397 |
12:07 ET | 991 | 1.035 |
12:09 ET | 871 | 1.03 |
12:12 ET | 2600 | 1.035 |
12:14 ET | 737 | 1.0323 |
12:16 ET | 127 | 1.035 |
12:18 ET | 2769 | 1.031 |
12:20 ET | 2444 | 1.035 |
12:21 ET | 200 | 1.03 |
12:23 ET | 340 | 1.03 |
12:25 ET | 827 | 1.03 |
12:27 ET | 2100 | 1.04 |
12:30 ET | 177 | 1.035 |
12:32 ET | 5071 | 1.035 |
12:34 ET | 7100 | 1.03 |
12:36 ET | 1345 | 1.035 |
12:38 ET | 1507 | 1.04 |
12:39 ET | 5225 | 1.035 |
12:41 ET | 29087 | 1.035 |
12:45 ET | 600 | 1.035 |
12:48 ET | 1433 | 1.03 |
12:50 ET | 2688 | 1.03 |
12:52 ET | 4883 | 1.035 |
12:54 ET | 1511 | 1.035 |
12:56 ET | 671 | 1.031 |
12:57 ET | 570 | 1.035 |
12:59 ET | 1099 | 1.03 |
01:01 ET | 5631 | 1.03 |
01:03 ET | 6600 | 1.035 |
01:06 ET | 577 | 1.03 |
01:08 ET | 526 | 1.035 |
01:10 ET | 7600 | 1.03 |
01:12 ET | 270 | 1.03 |
01:14 ET | 1621 | 1.03 |
01:15 ET | 100 | 1.03 |
01:17 ET | 976 | 1.03 |
01:19 ET | 300 | 1.03 |
01:21 ET | 4670 | 1.04 |
01:24 ET | 1076 | 1.035 |
01:26 ET | 154 | 1.03 |
01:28 ET | 172 | 1.035 |
01:30 ET | 600 | 1.03 |
01:32 ET | 1073 | 1.035 |
01:33 ET | 800 | 1.03 |
01:35 ET | 771 | 1.035 |
01:37 ET | 3944 | 1.03 |
01:39 ET | 128773 | 1.02 |
01:42 ET | 500 | 1.0299 |
01:44 ET | 1093 | 1.02 |
01:46 ET | 695 | 1.02 |
01:48 ET | 1642 | 1.02 |
01:50 ET | 3500 | 1.02 |
01:51 ET | 32594 | 1.025 |
01:53 ET | 8700 | 1.03 |
01:55 ET | 11202 | 1.025 |
01:57 ET | 1400 | 1.025 |
02:00 ET | 55053 | 1.025 |
02:02 ET | 9327 | 1.025 |
02:04 ET | 2250 | 1.02 |
02:06 ET | 3970 | 1.02 |
02:08 ET | 1800 | 1.02 |
02:09 ET | 9300 | 1.025 |
02:11 ET | 100 | 1.025 |
02:13 ET | 1400 | 1.02 |
02:15 ET | 7538 | 1.025 |
02:20 ET | 400 | 1.02 |
02:22 ET | 7000 | 1.025 |
02:24 ET | 1500 | 1.02 |
02:26 ET | 1540 | 1.02 |
02:27 ET | 300 | 1.02 |
02:29 ET | 710 | 1.02 |
02:31 ET | 7891 | 1.025 |
02:33 ET | 1000 | 1.025 |
02:36 ET | 484 | 1.02 |
02:38 ET | 11376 | 1.03 |
02:40 ET | 7282 | 1.025 |
02:42 ET | 300 | 1.02 |
02:44 ET | 548 | 1.025 |
02:45 ET | 300 | 1.02 |
02:47 ET | 7148 | 1.025 |
02:49 ET | 8216 | 1.0214 |
02:51 ET | 200 | 1.025 |
02:54 ET | 13116 | 1.025 |
02:56 ET | 529 | 1.025 |
02:58 ET | 244 | 1.02 |
03:00 ET | 1259 | 1.0228 |
03:02 ET | 1821 | 1.02 |
03:03 ET | 1287 | 1.02 |
03:05 ET | 674 | 1.02 |
03:07 ET | 170 | 1.025 |
03:09 ET | 55026 | 1.025 |
03:12 ET | 3372 | 1.025 |
03:14 ET | 8382 | 1.025 |
03:16 ET | 8406 | 1.02 |
03:18 ET | 6600 | 1.02 |
03:20 ET | 12139 | 1.02 |
03:21 ET | 3529 | 1.02 |
03:23 ET | 7138 | 1.0288 |
03:27 ET | 4918 | 1.025 |
03:30 ET | 4200 | 1.02 |
03:32 ET | 2152 | 1.03 |
03:34 ET | 700 | 1.02 |
03:36 ET | 300 | 1.02 |
03:38 ET | 3500 | 1.025 |
03:39 ET | 1970 | 1.02 |
03:41 ET | 12480 | 1.0299 |
03:45 ET | 600 | 1.02 |
03:48 ET | 21785 | 1.025 |
03:50 ET | 6224 | 1.025 |
03:52 ET | 3000 | 1.025 |
03:54 ET | 4605 | 1.025 |
03:56 ET | 18100 | 1.025 |
03:57 ET | 3489 | 1.02 |
03:59 ET | 36517 | 1.04 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adaptimmune Therapeutics PLC | 268.3M | -1.4x | --- |
Innate Pharma SA | 231.3M | -28.5x | --- |
MacroGenics Inc | 285.0M | -11.6x | --- |
Poseida Therapeutics Inc | 288.0M | -2.4x | --- |
Codexis Inc | 223.7M | -3.3x | --- |
Genfit SA | 226.8M | -7.4x | --- |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types. Its cell therapy candidates include TCR T-cells and TruC T-cells. Its product candidates include afamitresgene autoleucel (afami-cel) and Lete-cel. The afamicel is a cell therapy that provides a treatment option for people with synovial sarcoma. The Company is in the process of transitioning lete-cel, which targets the NY-ESO antigen in people with synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Its clinical pipeline includes SURPASS-III Phase II Trial with ADP-A2M4CD8 and SURPASS Phase I Trial with ADP-A2M4CD8. The Company’s most advanced pre-clinical programs are for T-cell therapies directed to the PRAME target (ADP-600) and to CD70 (ADP-520). ADAP-600 is an engineered TCR T-cell.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $268.3M |
---|---|
Revenue (TTM) | $18.4M |
Shares Outstanding | 255.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.30 |
EPS | $-0.73 |
Book Value | $0.17 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 14.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -918.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.